Pression, Inc., a medical technology innovator specializing in non-invasive circulatory health, announced today that it has received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for its Wave PRO™ External Counter-Pulsation (ECP) System. This milestone clearance allows Pression to commercially market its patented, cardiac-gated compression technology for...